United Health (UNH) Offering Possible 23.46% Return Over the Next 9 Calendar Days

United Health's most recent trend suggests a bullish bias. One trading opportunity on United Health is a Bull Put Spread using a strike $247.50 short put and a strike $242.50 long put offers a potential 23.46% return on risk over the next 9 calendar days. Maximum profit would be generated if the Bull Put Spread were to expire worthless, which would occur if the stock were above $247.50 by expiration. The full premium credit of $0.95 would be kept by the premium seller. The risk of $4.05 would be incurred if the stock dropped below the $242.50 long put strike price.

The 5-day moving average is moving up which suggests that the short-term momentum for United Health is bullish and the probability of a rise in share price is higher if the stock starts trending.

The 20-day moving average is moving up which suggests that the medium-term momentum for United Health is bullish.

The RSI indicator is at 67.71 level which suggests that the stock is neither overbought nor oversold at this time.

To learn how to execute such a strategy while accounting for risk and reward in the context of smart portfolio management, and see how to trade live with a successful professional trader, view more here

LATEST NEWS for United Health

Dow Jones Today: A Treat From the October Jobs Report
Fri, 01 Nov 2019 20:21:25 +0000
Yes, Halloween was yesterday, but endure one more related pun: The October jobs report that was released earlier today didn't trick investors. Rather, it a provided a treat that boosted stocks to end the week and start November on the right foot.Source: Venturelli Luca / Shutterstock.com The major equity benchmarks rallied today after the Labor Department said U.S. employers added 128,000 new jobs last month, well ahead of the 85,000 economists were expecting. That against the backdrop of massive layoffs in the automotive industry and the loss of about 20,000 temporary 2020 census workers. Additionally, the September number was revised higher to reflect the addition of 180,000 jobs.While unemployment inched up to 3.6%, it's still low by historical standards and average hourly earnings rose 3% in October. Remember, today's jobs report comes just a couple of days after the Federal Reserve lowered interest rates for the third time this year. Following the most recent FOMC meeting, the central bank noted it's rate-cutting regime may be on hold for awhile and the data seem to support that stance.InvestorPlace – Stock Market News, Stock Advice & Trading TipsAnother rate cut may not be coming anytime soon, but markets didn't care about that today as the Nasdaq Composite jumped 1.13% while the S&P 500 rallied by 0.97%. The Dow Jones Industrial Average advanced by 1.11% with 19 of its 30 components pointed higher in late trading. Surprises In the Winners ColumnTwo of the Dow's four healthcare components eked out gains today and pharmacy operator Walgreen Boots Alliance (NASDAQ:WBA), a consumer staples stock with significant healthcare exposure, surged nearly 5%. * 10 Stocks That Every 30-Year-Old Should Buy and Hold Forever However, the real story among Dow healthcare names and it's related to WBA's rally, is the gain, albeit modest, for UnitedHealth (NYSE:UNH). Indulge my speculation for a moment because I suspect UnitedHealth and rival managed care stocks were in the green today because Democratic frontrunner Sen. Elizabeth Warren (D-MA) finally detailed costs for her proposed Medicare For All plan."Investors have deemed the Sanders plan to be untenable, at least as laid out in its initial form," said Jeffries analyst Jared Holz, reports Barron's. "We think the Warren proposal, along with its $52 trillion price tag, will also be met with skepticism to say the least and likely viewed as a non-starter by many. Early feedback suggests this is the case. "Putting $52 trillion into context, that's roughly 52 Apple Inc's (NASDAQ:AAPL). Speaking of AppleIt was just another day at the office for the iPhone maker as the shares jumped 2.50%, starting November on healthy note after posting a double-digit gain last month.One of the more relevant Apple news items out today was the company asking the Trump administration to relax China-related tariffs on some important products, such as the iPhone 11 and Apple Watches."The company on Thursday sought tariff exclusions from 11 products, including HomePod speakers, iMac computers, parts for use in repairing iPhones, iPhone smart battery cases, AirPods and others," reports Reuters. Oil EarningsExxon Mobil (NYSE:XOM) and Chevron (NYSE:CVX), the two largest domestic oil companies and both Dow components, reported third-quarter earnings today. Exxon gained 2.77% to rank as one of the best-performing names in the Dow today while Chevron traded slightly lower.While down by a wide margin on a year-over-year basis, Exxon's third-quarter profit of $3.17 billion, or 75 cents per share, beat the 67 cents a share Wall Street was expecting.Chevron's third-quarter profit fell 36% to $2.58 billion, or $1.36 per share. On an adjusted basis, the company earned $1.55 a share, topping the consensus estimate of $1.45. Bottom Line in the Dow Jones TodayThere are few big-name earnings reports out next week, including Walt Disney (NYSE:DIS) among Dow components, but overall just 3% of the S&P 500 reports next week. So I'll take this opportunity for a brief review of how this earnings season has progressed."To date, 71% of the companies in the S&P 500 have reported actual results for Q3 2019. In terms of earnings, the percentage of companies reporting actual EPS above estimates (76%) is above the 5-year average," according to FactSet research. "In aggregate, companies are reporting earnings that are 3.8% above the estimates, which is below the 5-year average. In terms of sales, the percentage of companies (61%) reporting actual sales above estimates is above the 5-year average. In aggregate, companies are reporting sales that are 0.9% above estimates, which is also above the 5-year average."As of this writing, Todd Shriber did not hold a position in any of the aforementioned securities. More From InvestorPlace * 2 Toxic Pot Stocks You Should Avoid * 7 Buy-and-Hold Stocks to Play Investing's Biggest Trends * 7 Stocks to Buy in November * 5 Strong Buy Stocks Under $5 With Massive Upside Potential The post Dow Jones Today: A Treat From the October Jobs Report appeared first on InvestorPlace.

MEDNAX (MD) Q3 Earnings In Line With Estimates, Decline Y/Y
Fri, 01 Nov 2019 15:53:03 +0000
MEDNAX's (MD) results reflect escalating expenses in the third quarter.

Health-Insurance Stocks Rise as Elizabeth Warren Details Plan for Medicare for All
Fri, 01 Nov 2019 15:35:00 +0000
Managed-care stocks gained as the Democratic presidential candidate laid out her proposal, which would effectively replace the health-insurance system with a government-run program.

Why Alphabet’s Acquisition of Fitbit Is a Master Move
Fri, 01 Nov 2019 14:46:14 +0000
Earlier in the week, there was lots of buzz that Alphabet (NASDAQ:GOOGL, NASDAQ:GOOG) would acquire Fitbit (NYSE:FIT), whose shares spiked more than 15% today on the news (the main report came from Reuters). While such rumors often fizzle, this one certainly did not. Today the announcement hit the wires: Google has agreed to shell out $2.1 billion for the company. All in all, I think the deal is a spot on — and should be a catalyst for Google stock.Source: Shutterstock True, it's still relatively small, as Alphabet's market cap is a whopping $870 billion. Yet, Fit is likely going to provide quite a bit of leverage. Let's face it, Google has tried to get a piece of the wearables market with its Wear OS. However, there has been little progress so far. How Fitbit Benefits Google StockSo with Fit, Google will have about 6% of the global market (this is based on data from IDC). This will definitely be a good launching pad. According to Fitbit CEO and co-founder James Park: "Google is an ideal partner to advance our mission. With Google's resources and global platform, Fitbit will be able to accelerate innovation in the wearables category, scale faster, and make health even more accessible to everyone. I could not be more excited for what lies ahead."InvestorPlace – Stock Market News, Stock Advice & Trading TipsBut perhaps the biggest benefit — in terms of the impact on Google stock — would be the healthcare opportunity. During the past few years, Fitbit has gotten traction with striking deals with health plans. The company has also been working hard to get FDA approvals.Oh, and yes, there is the treasure trove of data, which extends 10-plus years. Note that Google is a global leader in AI and this technology will likely prove extremely useful in transforming the healthcare industry. As CEO Sundar Pichai noted on the latest earnings call, the company continues to push the boundaries of innovation, such as with the creation of a new kind of neural network that improves web services as well as breakthroughs in quantum computing. * 7 Triple-A Stocks to Buy in November But the fast-growing cloud business should also be a driver for Google stock when it comes to healthcare. In September, the company announced a partnership with the Mayo Clinic to help with clinical experiences, diagnosis and research."Since Google has numerous health initiatives at present, those should complement what Fitbit brings to the table," said James Cassel, who is the chairman and co-founder of investment banking firm Cassel Salpeter & Co. (in an email interview). "Access to the installed base could be very helpful to Google's healthcare initiative Project Baseline – a partnership with Duke University School of Medicine, Stanford Medicine and the American Heart Association – as well as other health-centric projects they are working on. Access to big data is crucial for the future of healthcare and Fitbit has access to a lot of information." Bottom Line on the Alphabet Stock PriceThe wearables market is simply too large for Google to ignore. For example, as seen with Apple's (NASDAQ:AAPL) latest earnings report, the category is quite lucrative and a source of strong growth.The company's assortment of products — like the Watch, HomePod smart speaker and AirPods — generated revenues of $6.5 billion in the latest quarter, up 54% on a year-over-year basis (this is nearly as much as the Mac business!) In fact, AAPL has gotten traction with its Watch in deals with United Health (NYSE:UNH) and CVS (NYSE:CVS).True, Fitbit has its issues. Growth has been lagging and the competition has remained intense. But again, Google should be an ideal partner — which should allow for a classic win-win partnership.Tom Taulli is the author of the book, Artificial Intelligence Basics: A Non-Technical Introduction. Follow him on Twitter at @ttaulli. As of this writing, he did not hold a position in any of the aforementioned securities. More From InvestorPlace * 2 Toxic Pot Stocks You Should Avoid * 7 Buy-and-Hold Stocks to Play Investing's Biggest Trends * 7 Stocks to Buy in November * 5 Strong Buy Stocks Under $5 With Massive Upside Potential The post Why Alphabet's Acquisition of Fitbit Is a Master Move appeared first on InvestorPlace.

Ensign Group's (ENSG) Q3 Earnings Miss Estimates, Rise Y/Y
Thu, 31 Oct 2019 16:09:04 +0000
Ensign Group's (ENSG) third-quarter earnings suffer escalating expenses.

Related Posts

 

MarketTamer is not an investment advisor and is not registered with the U.S. Securities and Exchange Commission or the Financial Industry Regulatory Authority. Further, owners, employees, agents or representatives of MarketTamer are not acting as investment advisors and might not be registered with the U.S. Securities and Exchange Commission or the Financial Industry Regulatory.


This company makes no representations or warranties concerning the products, practices or procedures of any company or entity mentioned or recommended in this email, and makes no representations or warranties concerning said company or entity’s compliance with applicable laws and regulations, including, but not limited to, regulations promulgated by the SEC or the CFTC. The sender of this email may receive a portion of the proceeds from the sale of any products or services offered by a company or entity mentioned or recommended in this email. The recipient of this email assumes responsibility for conducting its own due diligence on the aforementioned company or entity and assumes full responsibility, and releases the sender from liability, for any purchase or order made from any company or entity mentioned or recommended in this email.


The content on any of MarketTamer websites, products or communication is for educational purposes only. Nothing in its products, services, or communications shall be construed as a solicitation and/or recommendation to buy or sell a security. Trading stocks, options and other securities involves risk. The risk of loss in trading securities can be substantial. The risk involved with trading stocks, options and other securities is not suitable for all investors. Prior to buying or selling an option, an investor must evaluate his/her own personal financial situation and consider all relevant risk factors. See: Characteristics and Risks of Standardized Options. The www.MarketTamer.com educational training program and software services are provided to improve financial understanding.


The information presented in this site is not intended to be used as the sole basis of any investment decisions, nor should it be construed as advice designed to meet the investment needs of any particular investor. Nothing in our research constitutes legal, accounting or tax advice or individually tailored investment advice. Our research is prepared for general circulation and has been prepared without regard to the individual financial circumstances and objectives of persons who receive or obtain access to it. Our research is based on sources that we believe to be reliable. However, we do not make any representation or warranty, expressed or implied, as to the accuracy of our research, the completeness, or correctness or make any guarantee or other promise as to any results that may be obtained from using our research. To the maximum extent permitted by law, neither we, any of our affiliates, nor any other person, shall have any liability whatsoever to any person for any loss or expense, whether direct, indirect, consequential, incidental or otherwise, arising from or relating in any way to any use of or reliance on our research or the information contained therein. Some discussions contain forward looking statements which are based on current expectations and differences can be expected. All of our research, including the estimates, opinions and information contained therein, reflects our judgment as of the publication or other dissemination date of the research and is subject to change without notice. Further, we expressly disclaim any responsibility to update such research. Investing involves substantial risk. Past performance is not a guarantee of future results, and a loss of original capital may occur. No one receiving or accessing our research should make any investment decision without first consulting his or her own personal financial advisor and conducting his or her own research and due diligence, including carefully reviewing any applicable prospectuses, press releases, reports and other public filings of the issuer of any securities being considered. None of the information presented should be construed as an offer to sell or buy any particular security. As always, use your best judgment when investing.